These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10668731)

  • 1. Spinal cord astrocytoma: response to PCV chemotherapy.
    Henson JW; Thornton AF; Louis DN
    Neurology; 2000 Jan; 54(2):518-20. PubMed ID: 10668731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: a Medical Research Council trial.
    Medical Research Council Brain Tumor Working Party
    J Clin Oncol; 2001 Jan; 19(2):509-18. PubMed ID: 11208845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procarbazine, lomustine, and vincristine (PCV) chemotherapy for anaplastic astrocytoma: A retrospective review of radiation therapy oncology group protocols comparing survival with carmustine or PCV adjuvant chemotherapy.
    Prados MD; Scott C; Curran WJ; Nelson DF; Leibel S; Kramer S
    J Clin Oncol; 1999 Nov; 17(11):3389-95. PubMed ID: 10550132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of accelerated fractionation radiation therapy with carboplatin followed by PCV chemotherapy for the treatment of anaplastic gliomas.
    Levin VA; Yung WK; Bruner J; Kyritsis A; Leeds N; Gleason MJ; Hess KR; Meyers CA; Ictech SA; Chang E; Maor MH
    Int J Radiat Oncol Biol Phys; 2002 May; 53(1):58-66. PubMed ID: 12007942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent modified PCV chemotherapy and radiotherapy in newly diagnosed grade IV astrocytoma.
    Murphy C; Pickles T; Knowling M; Thiesse B
    J Neurooncol; 2002 May; 57(3):215-20. PubMed ID: 12125984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy with carmustine and cisplatin followed by procarbazine, lomustine, and vincristine for adult high-grade astrocytoma.
    Liau CT; Wei KC; Tseng CK; Jung SM
    Chang Gung Med J; 2005 Jan; 28(1):16-23. PubMed ID: 15804144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procarbazine, CCNU and vincristine (PCV) combination chemotherapy for brain tumors.
    Brufman G; Halpern J; Sulkes A; Catane R; Biran S
    Oncology; 1984; 41(4):239-41. PubMed ID: 6462602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PC or PCV, That Is the Question: Primary Anaplastic Oligodendroglial Tumors Treated with Procarbazine and CCNU With and Without Vincristine.
    Webre C; Shonka N; Smith L; Liu D; De Groot J
    Anticancer Res; 2015 Oct; 35(10):5467-72. PubMed ID: 26408710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas.
    Levin VA; Prados MR; Wara WM; Davis RL; Gutin PH; Phillips TL; Lamborn K; Wilson CB
    Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):75-83. PubMed ID: 7721642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404.
    Prados MD; Seiferheld W; Sandler HM; Buckner JC; Phillips T; Schultz C; Urtasun R; Davis R; Gutin P; Cascino TL; Greenberg HS; Curran WJ
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1147-52. PubMed ID: 15001257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCNU overdose during PCV chemotherapy for anaplastic astrocytoma.
    Abele M; Leonhardt M; Dichgans J; Weller M
    J Neurol; 1998 Apr; 245(4):236-8. PubMed ID: 9591226
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and feasibility of standard procarbazine, lomustine, and vincristine chemotherapy in anaplastic oligodendroglioma and oligoastrocytoma recurrent after radiotherapy. A Phase II study.
    Brandes AA; Tosoni A; Vastola F; Pasetto LM; Coria B; Danieli D; Iuzzolino P; Gardiman M; Talacchi A; Ermani M
    Cancer; 2004 Nov; 101(9):2079-85. PubMed ID: 15372474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapy.
    Glass J; Hochberg FH; Gruber ML; Louis DN; Smith D; Rattner B
    J Neurosurg; 1992 May; 76(5):741-5. PubMed ID: 1564535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical Research Council adjuvant trial in high-grade gliomas.
    Chamberlain MC; Jaeckle KA
    J Clin Oncol; 2001 Oct; 19(19):3997-9. PubMed ID: 11579124
    [No Abstract]   [Full Text] [Related]  

  • 15. [Neoadjuvant chemotherapy for symptomatic non operable grade II fibrillary astrocytoma in adults].
    Lebrun C; Fontaine D; Vandenbos F; Chanalet S; Bourg V; Frénay M; Alchaar H; Bleuse A; Bondiau PY; Brunetto JL; Chatel M; Courdi A; Darcourt J; Fauchon F; Guibert F; Grellier P; Lanteri-Minet M; Lonjon M; Michiels JF; Paquis P; Paquis V; Ramaioli A; Rasendrarijao D;
    Rev Neurol (Paris); 2004 May; 160(5 Pt 1):533-7. PubMed ID: 15269670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of 6-thioguanine, procarbazine, dibromodulcitol, lomustine, and vincristine chemotherapy with radiotherapy for treating malignant glioma in children.
    Levin VA; Lamborn K; Wara W; Davis R; Edwards M; Rabbitt J; Malec M; Prados MD
    Neuro Oncol; 2000 Jan; 2(1):22-8. PubMed ID: 11302250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities.
    Buckner JC; Gesme D; O'Fallon JR; Hammack JE; Stafford S; Brown PD; Hawkins R; Scheithauer BW; Erickson BJ; Levitt R; Shaw EG; Jenkins R
    J Clin Oncol; 2003 Jan; 21(2):251-5. PubMed ID: 12525516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy for spinal cord astrocytoma.
    Bouffet E; Amat D; Devaux Y; Desuzinges C
    Med Pediatr Oncol; 1997 Dec; 29(6):560-2. PubMed ID: 9324344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
    Levin VA; Uhm JH; Jaeckle KA; Choucair A; Flynn PJ; Yung WKA ; Prados MD; Bruner JM; Chang SM; Kyritsis AP; Gleason MJ; Hess KR
    Clin Cancer Res; 2000 Oct; 6(10):3878-84. PubMed ID: 11051233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BUdR for the treatment of anaplastic astrocytoma: a preliminary report of RTOG 9404.
    Prados MD; Scott C; Sandler H; Buckner JC; Phillips T; Schultz C; Urtasun R; Davis R; Gutin P; Cascino TL; Greenberg HS; Curran WJ
    Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1109-15. PubMed ID: 10613302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.